Timing of Complete Revascularization in Patients with STEMI and Multivessel Disease: A Systematic Review and Meta-Analysis
Reviews in Cardiovascular Medicine · 10.02.2023 · 24 (2)
DOI: 10.31083/j.rcm2402058 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 10.02.2023. Verfasst von Giuseppe Panuccio und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Magna Graecia University, 88100 Catanzaro, Italy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
About half of patients with ST-segment Elevation Myocardial Infarction (STEMI) have multivessel coronary artery disease (MVD). Our aim was to provide a quantitative comparison of single-stage complete revascularization during the index revascularization versus deferred staged complete revascularization in STEMI patients with MVD.
Methods
All studies evaluating patients with STEMI and MVD were included. The primary endpoint was a composite of all-cause death, myocardial infarction and repeat revascularization. Secondary endpoints were cardiovascular death, acute kidney injury and trial defined major bleeding.
Results
Eight studies and 2256 patients with STEMI and MVD were included. No difference was evident in the rate of the primary composite endpoint among the study group (Risk Ratio 0.95; 95% CI 0.71–1.27, p = 0.74), while meta-regression showed a significant interaction with drug eluting stent (DES) use (Coefficient –0.005; 95% CI –0.01 to –0.001; p = 0.007). Higher rates of cardiovascular (CV) death were found in the immediate complete revascularization group (5.0% vs 2.6%; Risk Ratio 0.39; 95% CI 0.25–0.62; p < 0.01).
Conclusions
Our analysis documented similar clinical outcomes with either single-stage immediate complete revascularization and delayed staged complete revascularization. Secondary analyses suggest that an increase in cardiovascular death might be expected with single-stage percutaneous coronary intervention (PCI). While new randomized trials on the topic are ongoing, revascularization can be personalized and guided by the acute clinical setting, patients’-related factors and workflow logistics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, Magna Graecia University, 88100 Catanzaro, Italy.
- Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy.
Zitieren
APA
Panuccio, G., Salerno, N., De Rosa, S., & Torella, D. (2023). Timing of Complete Revascularization in Patients with STEMI and Multivessel Disease: A Systematic Review and Meta-Analysis. Reviews in Cardiovascular Medicine, 24(2). https://doi.org/10.31083/j.rcm2402058
Vancouver
Panuccio G, Salerno N, De Rosa S, Torella D. Timing of Complete Revascularization in Patients with STEMI and Multivessel Disease: A Systematic Review and Meta-Analysis. Reviews in Cardiovascular Medicine. 2023;24(2). doi:10.31083/j.rcm2402058
BibTeX
@article{Panuccio2023,
author = {Panuccio, Giuseppe and Salerno, Nadia and De Rosa, Salvatore and Torella, Daniele},
title = {Timing of Complete Revascularization in Patients with STEMI and Multivessel Disease: A Systematic Review and Meta-Analysis},
journal = {Reviews in Cardiovascular Medicine},
year = {2023},
volume = {24},
number = {2},
doi = {10.31083/j.rcm2402058}
}
EUVIMED